Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
85 Cards in this Set
- Front
- Back
Acute therapy for fatty acid oxidation defects
|
IV fluids with 10% dextrose, maybe with bicarbonate
|
|
prognosis for untreated LCHAD/VLCHAD
|
potentially fatal acute metabolic crises, heart failure from cardiomyopathy
|
|
Another name for glutaric acidemia type II
|
MAD deficiency
|
|
3 clinical types of glutaric acidemia type II
|
1. neonatal onset with congenital anomalies
2. neonatal onset without congenital anomalies 3. later onset |
|
Enzyme defective in glutaric acidemia type II
|
electron transfer flavoprotein or EFT-DH
|
|
What effect can fatty acid oxidation disorders have on the brain?
|
encephalopathy
|
|
Effect of untreated glutaric acidemia type II on neonates
|
usually don't survive
|
|
cofactor needed for glutaric acidemia type II
|
riboflavin
|
|
Causes of encephalopathy in FAODs
|
metabolic acidosis, hypoglycemia, big fats wandering around can be neurotoxic. But the main cause is the lack of ketones for energy when the sugar runs out. Can lead to coma and death.
|
|
What ultimately causes symptoms in FAODs?
|
Not hypoglycemia, but lack of ability to have energy from fats. Also, accumulation of fats
|
|
Clinical features of all FAODs.
|
fasting intolerance, coma, seizure, liver dysfunction
|
|
Cardiomyopathy occus in which of the FAODs?
|
Mostly in the longer chain FA oxidation disorders and carnitine transport defects
|
|
Congenital anomalies occur in which of the FAODs?
|
Mostly in severe CPT II deficiency and glutaric acidemia type II
|
|
What happens to free carnitine in organic acidemias and FAODs?
|
Extra metabolites bind carnitine, so free carnitine is low, and other things are high (acylcarnitines, acylglycines, organic acids)
|
|
In FAODs, what 3 tests will show abnormalities with respect to carnitine levels?
|
acylcarnitine, acylglycine, organic acids
|
|
Features of acute fatty liver of pregnancy
|
abdominal pain, nausea, voming in 3rd trimester, hypoglycemia, kidney and liver failure, coma, hemorrhage
|
|
Most common FAOD to cause HELLP or AFLP in pregnant women
|
LCHAD
|
|
Major symptoms of galactosemia
|
jaundice, bleding diathesis, feeding problems, irritability, lethargy, sepsis, cataracts
|
|
long-term complications of galactosemia
|
dev. delay, language delay, motor delay, premature ovarian failure, diminished bone density
|
|
Immediate newborn therapy for galactosemia
|
soy formula only, watch for sepsis, treat liver disease
|
|
Long-term treatment for galactosemia
|
lactose-free diet, calcium supplementation, watch bone density and eyes, ovarian function, developmental support
|
|
Lysosomes are most prevalent in what type of cells?
|
white blood cells
|
|
Molecules targeted to the lysosomes for breakdown have what added to them?
|
mannose-6-phosphate
|
|
Name 2 X-linked lysomal storage disorders
|
Hunter, Fabry
|
|
Organ systems affected by lysosomal storage diseases
|
liver, spleen, bones, lungs, brain, kidneys, heart
|
|
Enzyme missing in Gaucher
|
Beta-Glucocerebrosidase A
|
|
Type of cancer risk for Gaucher
|
multiple myeloma
|
|
Name of the recombinant enzyme used to treat Gaucher
|
cerezyme
|
|
What tissues are aided by enzyme replacement therapy in Gaucher? What tissues can't be helped?
|
Soft tissues are improved, bone and brain can't be helped.
|
|
Skin manifestations of infantile Gaucher
|
hydrops fetalis, collodion skin and lamellar ichthyosis
|
|
Describe Type III Gaucher
|
subacute--organ involvement in 1st decade. Then in late childhood, start getting ataxia, paraplegia, dementia, seizures
|
|
What happens in Fabry disease?
|
Males affected--cells that line blood vessels are missing an enzyme, so don't get blood to capillaries properly. Affects gut, kidney, heart, limbs. Stroke, but not cognitive impairment. Extremely painful extremities, always miserable.
|
|
Eye findings associated with Fabry disease
|
Corneal opacity, spoke pattern, vision itself is fine, affects both genders, even female carriers, tortuous vessels in retina
|
|
Patients with Pompe disease can's tstore what?
|
glycogen
|
|
Systems most affected by Pompe disease
|
cardiac and skeletal muscle
|
|
Name 2 treatments for mucopolysaccharidoses
|
bone marrow transplant, enzyme replacement
|
|
Treatment for a newborn with Hurler syndrome
|
bone marrow transplant--source of enzyme that will cross the BBB
|
|
Gene mutated in Gaucher
|
GBA
|
|
Three subtypes of Gaucher
|
non-neuronopathic, infantile acute neuroopathic, subacute nueronopathic
|
|
Dysmorphic features in Zellweger
|
low broad nasal bridge, high forehead, flattened occiput, high arched palate, micrognathia
|
|
Eye findings in Zellweger
|
optic atrophy, cataracts
|
|
kidney findings in Zellweger
|
renal cortical cysts
|
|
eye findings in infantile Refsum
|
RP
|
|
What percent of female carriers of X-linked ALD will have symptoms?
|
20%
|
|
If you have a homoplasmic LHON mutation, what is the likelihood that you will go blind, based on gender?
|
males=40% (60% are fine)
females=10% males are 4X more likely to be affected, no one know why |
|
What % of childhood hearing loss is due to mitochondrial mutations?
|
about 5%
|
|
Mutations in the 12S rRNA (A1555G) of mitochondria may cause what?
|
hearing loss-often multifactorial and environmental-aminoglycosides
|
|
Name 2 conditions caused by homoplasmic mitochondrial mutations
|
LHON
hearing loss |
|
Features of Mohr-Tranebjaerg
|
sensorineural deafness
dystonia dysphagia blindness paranoia |
|
Gene and inheritance of Mohr-Tranebjaerg
|
DDP1
X-linked involved in importing proteins into mitochondria |
|
Explain how insufficient frataxin causes Friedreich ataxia
|
Frataxin is a mitochondrial iron chaperone that makes iron available to complexes in electron tansport chain. If frataxin is absent, iron overload occurs and mitochondria are dysfunctional.
|
|
Part of body most affected in Leigh syndrome
|
bottom of the brain-basal ganglia, brain stem, cerebellum
|
|
Causes of Leigh disease
|
nuclear-encoded Complex I genes
nuclear-encoded Complex II genes nuclear-encoded Complex IV genes mito-encoded Complex V gene X-linked E1 alpha |
|
Leigh disease caused by mutations in nuclear-encoded Complex II genes has what additional phenotype?
|
Leigh plus tumors--paraganglioma and pheochromocytoma
|
|
Up to 1/3 of cases of Leigh syndrome are due to mutations in what nuclear gene?
|
SURF1-assembly protein
|
|
T8993G/C-associated Leigh disease--what determines this vs another disease, and what is the other condition?
|
95% or more mutant heteroplasmy=Leigh
70-95% heteroplasmy =NARP (neuropathy, ataxia, and retinitis pigmentosa) |
|
2 genes associated with Autosomal Dominant Progressive External Ophthalmoplegia
|
ANT-1 (ATP can't leave mitochondria)
Twinkle (mtDNA replication fork can't unwind) |
|
Gene and inheritace assoc. with MNGIE
|
Thymidine phosphorylase
Usually autosomal recessive Causes an dexcess of T's in mtDNA pool, resulting in mtDNA deletions |
|
Liver failure might be indicative of what type of mitochondrial defect?
|
mtDNA depletion
|
|
How many trinucleotide repeats are supposed to be present in POLG?
|
10
|
|
Common MERRF mutation
|
A8344G
|
|
Common mutation for maternally-inherited Leigh or NARP
|
G8993T or C
|
|
Standard mtDNA molecular analysis consists of what?
|
PCR for 3 mutations: A3243G, A8344G, T8993G/C
Southern blotting for large rearrangements |
|
Most likely mode of inheritance for infantile onset, severe mitochondrial disease? Late-onset, less severe?
|
Infantile onset, severe=autosomal recessive
Late-onset, less severe=maternal mtDNA (many exceptions) |
|
Mitochondrial disease should be considered in any patient with 2 or more of what?
|
neuro-muscular-endocrine-renal tubular dysfunctions
|
|
Why is it so difficult to diagnose mitochondrial disease?
|
Msut get metabolite testing when patietn is stressed
DNA testing often not positive, even when disease is present May need muscle biopsy |
|
Important aspects of treatment for mitochondrial disease
|
increase energy supply, decrease demand
Avoid fasting-can save lives Anticipate certain symptoms |
|
If ammonia can't become urea, it becomes what? Why is this important?
|
glutamine
single most important nitrogen carrier in blood high glutamine in brain draws in water, causes swelling |
|
Non-metabolic conditions included in newborn screening, as recommended by ACMG
|
cystic fibrosis
hearing hemoglobinopathies hypothyroidism CAH |
|
Name some lysosomal storage disorders
|
Krabbe
MPS Gaucher Niemann-Pick Tay Sachs Fabry Pompe Sandhoff |
|
Sign of metabolic crisis in urine test, which is found in some organic acidopathies
|
ketonuria
|
|
Cure for MSUD
|
liver transplant
|
|
Gene assoc. with LCHAD
|
HADHA
|
|
Most common presentation of MCAD
|
hypoketotic hypoglycemia
|
|
Daily treatment for MCAD
|
uncooked cornstarch at bedtime to prevent fasting
|
|
Common symptoms of SCAD
|
hypotonia, DD
|
|
Incidence of PKU
|
1:4000 in Ireland and Turkey
1:10,000-15,000 in USA |
|
Incidence of galactosemia
|
1:60,000
|
|
Incidence of heterozygotes for familial hypercholesterolemia
|
1:500, but not all show signs
|
|
Features of X-linked chondrodysplasia punctata
|
rhizomelic shortening
postaxial polydactyly sparse hair cataracts contractures red flaky lesions on skin |
|
2 syndromes assoc. with the EBP gene
|
X-linked chondrodysplasia punctata
CHILD |
|
Incidence of X-linked ALD
|
1 in 42,000 males
|
|
What chemical is deficient in the brain in peroxisomal disorders, and should be given as a daily supplement?
|
DHA
|
|
What accumulates in Fabry disease?
|
glycosphingolipids
|
|
What X-linked lysosomal disorder affects males AND females
|
Fabry--female carriers display spectrum of phenotypes
|